News for Longboard Pharmaceuticals, Inc. (LBPH)

Connecticut lawmakers advanced a bill that would decriminalize psilocybin if ultimately passed. Investors were also cheered by a C-suite appointment. Mind Medicine (NASDAQ: MNMD), a healthcare company that's looking to develop treatments based on psychedelic compounds, was something of a sleeper stock in May. Several positive developments pushed the highly specialized enterprise's share price higher, to the point where it closed the month up almost 14% in price.

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates

New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension BOSTON, March 27, 2025 (GLOBE

**media[548530]**

On December 31, 2024, Cormorant Asset Management, LP (Trades, Portfolio) made a significant move by acquiring an additional 823,219 shares of Praxis Precision M

On December 31, 2024, Cormorant Asset Management, LP (Trades, Portfolio) made a strategic move by acquiring 609,027 shares of Kala Bio Inc at a price of $6.94 p

Baird initiated coverage of Bright Minds Biosciences (DRUG) with an outperform rating, citing the planned acquisition of rival Longboard Pharmaceuticals (LBPH). Read more here.

Cash Position: Cash, cash equivalents, and short-term investments totaled approximately $288.4 million as of September 30, 2024, indicating a strong liquidity

Overview of the Recent Transaction On November 6, 2024, FMR LLC (Trades, Portfolio) executed a significant transaction by reducing its holdings in Longboard Pha

Longboard Pharmaceuticals' $2.6B sale to Lundbeck clears regulatory hurdles as waiting periods expire, marking progress in acquisition process.

It’s been one wild ride for Bright Minds Biosciences (NASDAQ: DRUG), which skyrocketed an eye-popping 5,900% this week! Yes, you read that right—nearly six

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is...

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

BALA CYNWYD, Penn., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish...

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.8% on Monday. The Dow traded up 0.53% to 43,092.98 while the NASDAQ rose...

Shares of Longboard Pharmaceuticals, Inc. LBPH rose sharply in today's pre-market trading. Lundbeck agreed to acquire Longboard Pharmaceuticals in a transactio...

Longboard Pharmaceuticals, Inc. shares have surged in 2024 due to positive mid-stage trial data. Click here for more on the LBPH stock prospects.

In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks.